Verona Pharma Plc
| London Stock Exchange: VRP
Verona Pharma Plc researches and develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases. It engages in discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis, chronic obstructive pulmonary disease and cough. Verona Pharma was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.